Shlomo Yanai's Net Worth
$3.69 Million
Who is Shlomo Yanai?
Shlomo Yanai has an estimated net worth of $3.69 Million. This is based on reported shares across multiple companies, which include Philip Morris International Inc., Sagent Pharmaceuticals, Inc., Amneal Pharmaceuticals, Inc., PERRIGO Co plc, Protalix BioTherapeutics, Inc., Exela Technologies, Inc., CAMBREX CORP, PDL BIOPHARMA, INC., and W R GRACE & CO.
SEC CIK
Shlomo Yanai's CIK is 0001562645
Past Insider Trading and Trends
2019 was Shlomo Yanai's most active year for acquiring shares with 20 total transactions. Shlomo Yanai's most active month to acquire stocks was the month of April. 2016 was Shlomo Yanai's most active year for disposing of shares, totalling 5 transactions. Shlomo Yanai's most active month to dispose stocks was the month of April. 2019 saw Shlomo Yanai paying a total of $1,015,306.48 for 209,243 shares, this is the most they've acquired in one year. In 2019 Shlomo Yanai cashed out on 35,796 shares for a total of $2,147,760.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Philip Morris International Inc. (PM) Snapshot price: $125.81
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +31.32% | 1.79K |
$97.84 | $175,035.76 | 7.5K |
May 8
| |||
Form 4
| +49.05% | 1.81K |
$96.58 | $175,002.96 | 5.51K |
May 3
| |||
Form 4
| +95.65% | 1.76K |
$99.53 | $175,073.27 | 3.6K |
May 4
| |||
Form 4
|
∞
| 1.84K |
$95.18 | $175,026.83 | 1.84K |
May 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Sagent Pharmaceuticals, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -742.00 |
$21.75 | -$16,138.50 |
0
|
Aug 29
| |||
Form 4
|
∞
| 742 |
—
|
—
| 742 |
Apr 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 15
| |||
No matching records found |
Amneal Pharmaceuticals, Inc. (AMRX) Snapshot price: $8.39
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +45.17% | 76.45K |
—
|
—
| 245.73K |
May 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 2
| |||
Form 4
| +89.88% | 80.13K |
—
|
—
| 169.27K |
May 9 - May 10
| |||
Form 4
| +65.88% | 35.41K |
—
|
—
| 89.15K |
May 8 - May 9
| |||
Form 4
| +614.44% | 46.22K |
—
|
—
| 53.74K |
May 5 - May 6
| |||
Form 4
|
∞
| 7.52K |
—
|
—
| 7.52K |
Dec 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
PERRIGO Co plc (PRGO) Snapshot price: $27.7
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
|
∞
| 443 |
$95.70 | $42,395.10 | 443 |
May 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Protalix BioTherapeutics, Inc. (PLX) Snapshot price: $1.001
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |